The toxin–antitoxin complex Fic-1–AntF functions as a deAMPylase that regulates the activity of DNA gyrase

Abstract

Toxin–antitoxin (TA) systems found in diverse bacteria play important roles in their adaptation to changing environments. The toxin of the Fic-1–AntF TA pair from Pseudomonas bijieensis strain 2P24 inhibits bacterial DNA replication by attacking the subunit B of DNA gyrase (GyrB) via AMPylation, while the antitoxin AntF blocks its enzymatic activity by forming a stable protein complex. Although many proteins, including bacterial toxins, have been found to catalyze AMPylation, few enzymes involved in reversing this modification have been described. In this study, we found that the Fic-1–AntF complex functions as a deAMPylase to reverse GyrB modification imposed by Fic-1. Structural and genetic analyses of the Fic-1–AntF complex revealed that Glu28 of AntF is critical for catalysis. Thus, AntF not only functions to inhibit the activity of Fic-1 but also cooperates with the toxin to return the modified substrate to its native form by de-modification. Our results reveal a novel regulatory mechanism for bacterial toxin, which sheds light on the evolution of such enzymes, particularly those of multiple subunits.

Keywords

AMPylation / deAMPylation / Fic protein / post-translational modification / toxin–antitoxin

References

[1] Wang X, Kim Y, Hong SH, Ma Q, Brown BL, Pu M, et al. Antitoxin MqsA helps mediate the bacterial general stress response. Nat Chem Biol. 2011; 7: 359–366.

[2] Christensen SK, Mikkelsen M, Pedersen K, Gerdes K. RelE, a global inhibitor of translation, is activated during nutritional stress. Proc Natl Acad Sci USA. 2001; 98: 14328–14333.

[3] Pecota DC, Wood TK. Exclusion of T4 phage by the hok/sok killer locus from plasmid R1. J Bacteriol. 1996; 178: 2044–2050.

[4] Jurėnas D, Fraikin N, Goormaghtigh F, Van Melderen L. Biology and evolution of bacterial toxin–antitoxin systems. Nat Rev Microbiol. 2022; 20: 335–350.

[5] Choi JS, Kim W, Suk S, Park H, Bak G, Yoon J, et al. The small RNA, SdsR, acts as a novel type of toxin in Escherichia coli. RNA Biol. 2018; 15: 1319–1335.

[6] Song S, Wood TK. Toxin/antitoxin system paradigms: toxins bound to antitoxins are not likely activated by preferential antitoxin degradation. Adv Biosyst. 2020; 4: e1900290.

[7] Fozo EM, Kawano M, Fontaine F, Kaya Y, Mendieta KS, Jones KL, et al. Repression of small toxic protein synthesis by the Sib and OhsC small RNAs. Mol Microbiol. 2008; 70: 1076–1093.

[8] Kawano M, Aravind L, Storz G. An antisense RNA controls synthesis of an SOS-induced toxin evolved from an antitoxin. Mol Microbiol. 2007; 64: 738–754.

[9] Samson JE, Spinelli S, Cambillau C, Moineau S. Structure and activity of AbiQ, a lactococcal endoribonuclease belonging to the type III toxin-antitoxin system. Mol Microbiol. 2013; 87: 756–768.

[10] Short FL, Pei XY, Blower TR, Ong SL, Fineran PC, Luisi BF, et al. Selectivity and self-assembly in the control of a bacterial toxin by an antitoxic noncoding RNA pseudoknot. Proc Natl Acad Sci USA. 2012; 110: E241–E249.

[11] Jurėnas D, Van Melderen L, Garcia-Pino A. Mechanism of regulation and neutralization of the AtaR–AtaT toxin–antitoxin system. Nat Chem Biol. 2019; 15: 285–294.

[12] Lehnherr H, Maguin E, Jafri S, Yarmolinsky MB. Plasmid addiction genes of bacteriophage P1: doc, which causes cell death on curing of prophage, and phd, which prevents host death when prophage is retained. J Mol Biol. 1993; 233: 414–428.

[13] Jankevicius G, Ariza A, Ahel M, Ahel I. The toxin-antitoxin system DarTG catalyzes reversible ADP-ribosylation of DNA. Mol Cell. 2016; 64: 1109–1116.

[14] Masuda H, Tan Q, Awano N, Wu KP, Inouye M. YeeU enhances the bundling of cytoskeletal polymers of MreB and FtsZ, antagonizing the CbtA (YeeV) toxicity in Escherichia coli. Mol Microbiol. 2012; 84: 979–989.

[15] Wang X, Lord DM, Cheng HY, Osbourne DO, Hong SH, Sanchez-Torres V, et al. A new type V toxin-antitoxin system where mRNA for toxin GhoT is cleaved by antitoxin GhoS. Nat Chem Biol. 2012; 8: 855–861.

[16] Aakre CD, Phung TN, Huang D, Laub MT. A bacterial toxin inhibits DNA replication elongation through a direct interaction with the β sliding clamp. Mol Cell. 2013; 52: 617–628.

[17] Yu X, Gao X, Zhu K, Yin H, Mao X, Wojdyla JA, et al. Characterization of a toxin-antitoxin system in Mycobacterium tuberculosis suggests neutralization by phosphorylation as the antitoxicity mechanism. Commun Biol. 2020; 3: 216.

[18] Wang X, Yao J, Sun YC, Wood TK. Type VII toxin/antitoxin classification system for antitoxins that enzymatically neutralize toxins. Trends Microbiol. 2021; 29: 388–393.

[19] Li M, Gong L, Cheng F, Yu H, Zhao D, Wang R, et al. Toxin-antitoxin RNA pairs safeguard CRISPR-Cas systems. Science. 2021; 372:eabe5601.

[20] Worby CA, Mattoo S, Kruger RP, Corbeil LB, Koller A, Mendez JC, et al. The Fic domain: regulation of cell signaling by adenylylation. Mol Cell. 2009; 34: 93–103.

[21] Kinch LN, Yarbrough ML, Orth K, Grishin NV. Fido, a novel AMPylation domain common to Fic, Doc, and AvrB. PLoS One. 2009; 4:e5818.

[22] Woolery A. AMPylation: something old is new again. Front Microbiol. 2010; 1: 113–119.

[23] Engel P, Goepfert A, Stanger FV, Harms A, Schmidt A, Schirmer T, et al. Adenylylation control by intra- or intermolecular active-site obstruction in fic proteins. Nature. 2012; 482: 107–110.

[24] Lu C, Nakayasu ES, Zhang LQ, Luo ZQ. Identification of Fic-1 as an enzyme that inhibits bacterial DNA replication by AMPylating GyrB, promoting filament formation. Sci Signaling. 2016; 9: ra11.

[25] Oppenheim DS, Yanofsky C. Translational coupling during expression of the tryptophan operon of Escherichia coli. Genetics. 1980; 95: 785–795.

[26] Harms A, Stanger FV, Scheu PD, de Jong IG, Goepfert A, Glatter T, et al. Adenylylation of gyrase and topo IV by FicT toxins disrupts bacterial DNA topology. Cell Rep. 2015; 12: 1497–1507.

[27] Stanger FV, Harms A, Dehio C, Schirmer T. Crystal structure of the Escherichia coli Fic toxin-like protein in complex with its cognate antitoxin. PLoS One. 2016; 11:e0163654.

[28] Kingdon HS, Shapiro BM, Stadtman ER. Regulation of glutamine synthetase. 8. ATP: glutamine synthetase adenylyltransferase, an enzyme that catalyzes alterations in the regulatory properties of glutamine synthetase. Proc Natl Acad Sci USA. 1967; 58: 1703–1710.

[29] Müller MP, Peters H, Blümer J, Blankenfeldt W, Goody RS, Itzen A. The Legionella effector protein DrrA AMPylates the membrane traffic regulator Rab1b. Science. 2010; 329: 946–949.

[30] Sreelatha A, Yee SS, Lopez VA, Park BC, Kinch LN, Pilch S, et al. Protein AMPylation by an evolutionarily conserved pseudokinase. Cell. 2018; 175: 809–821.e19.

[31] Fu J, Li S, Guan H, Li C, Zhao YB, Chen TT, et al. Legionella maintains host cell ubiquitin homeostasis by effectors with unique catalytic mechanisms. Nat Commun. 2024; 15: 5953.

[32] Wang T, Song X, Tan J, Xian W, Zhou X, Yu M, et al. Legionella effector LnaB is a phosphoryl-AMPylase that impairs phosphosignalling. Nature. 2024; 631: 393–401.

[33] Jiang P, Mayo AE, Ninfa AJ. Escherichia coli glutamine synthetase adenylyltransferase (ATase, EC 2.7.7.49): kinetic characterization of regulation by PII, PII-UMP, glutamine, and α-ketoglutarate. Biochemistry. 2007; 46: 4133–4146.

[34] Anderson WB, Stadtman ER. Glutamine synthetase deadenylylation: a phosphorolytic reaction yielding ADP as nucleotide product. Biochem Biophys Res Commun. 1970; 41: 704–709.

[35] Tan Y, Luo ZQ. Legionella pneumophila SidD is a deAMPylase that modifies Rab1. Nature. 2011; 475: 506–509.

[36] Mukherjee S, Liu X, Arasaki K, McDonough J, Galán JE, Roy CR. Modulation of Rab GTPase function by a protein phosphocholine transferase. Nature. 2011; 477: 103–106.

[37] Chen Y, Tascón I, Neunuebel MR, Pallara C, Brady J, Kinch LN, et al. Structural basis for Rab1 de-AMPylation by the Legionella pneumophila effector SidD. PLoS Pathog. 2013; 9:e1003382.

[38] Tascón I, Li X, Lucas M, Nelson D, Vidaurrazaga A, Lin YH, et al. Structural insight into the membrane targeting domain of the Legionella deAMPylase SidD. PLoS Pathog. 2020; 16:e1008734.

[39] Preissler S, Rato C, Perera LA, Saudek V, Ron D. FICD acts bifunctionally to AMPylate and de-AMPylate the endoplasmic reticulum chaperone BiP. Nat Struct Mol Biol. 2017; 24: 23–29.

[40] Casey AK, Moehlman AT, Zhang J, Servage KA, Krämer H, Orth K. Fic-mediated deAMPylation is not dependent on homo-dimerization and rescues toxic AMPylation in flies. J Biol Chem. 2017; 292: 21193–21204.

[41] Perera LA, Preissler S, Zaccai NR, Prévost S, Devos JM, Haertlein M, et al. Structures of a deAMPylation complex rationalise the switch between antagonistic catalytic activities of FICD. Nat Commun. 2021; 12: 5004.

[42] Veyron S, Oliva G, Rolando M, Buchrieser C, Peyroche G, Cherfils J. A Ca²⁺-regulated deAMPylation switch in human and bacterial FIC proteins. Nat Commun. 2019; 10: 1142.

[43] Mukherjee M, Pon A, Goldberg T, Pawłowski K, Sreelatha A. Ribonuclease RNase Z is an evolutionarily conserved deAMPylase. Proc Natl Acad Sci USA. 2025; 122:e2515155122.

[44] Arrowsmith TJ, Xu X, Xu S, Usher B, Stokes P, Guest M, et al. Inducible auto-phosphorylation regulates a widespread family of nucleotidyltransferase toxins. Nat Commun. 2024; 15: 7719.

[45] Harms A, Stanger FV, Dehio C. Biological diversity and molecular plasticity of FIC domain proteins. Annu Rev Microbiol. 2016; 70: 341–360.

[46] Pasek S, Risler JL, Brézellec P. Gene fusion/fission is a major contributor to evolution of multi-domain bacterial proteins. Bioinformatics. 2006; 22: 1418–1423.

[47] Liu M, Li L, Wang Z, Wang S, Tang X. Catalytic deAMPylation in AMPylation-inhibitory/assistant forms of FICD protein. Front Chem. 2023; 11: 1077188.

[48] Wei HL, Zhang LQ. Quorum-sensing system influences root colonization and biological control ability in Pseudomonas fluorescens 2P24. Antonie Van Leeuwenhoek. 2006; 89: 267–280.

[49] Karimova G, Pidoux J, Ullmann A, Ladant D. A bacterial two-hybrid system based on a reconstituted signal transduction pathway. Proc Natl Acad Sci USA. 1998; 95: 5752–5756.

[50] Miller JH. Experiments in Molecular Genetics. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1972. p. 352–355

[51] Merrifield RB. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J Am Chem Soc. 1963; 85: 2149–2154.

[52] Guo L, Zhang Y, Ma M, Liu Q, Zhang Y, Peng Y, et al. Crystallization of the rice immune receptor RGA5A_S with the rice blast fungus effector AVR1-CO39 prepared via mixture and tandem strategies. Acta Crystallogr F Struct Biol Commun. 2018; 74: 262–267.

[53] McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. Phaser crystallographic software. J Appl Crystal. 2007; 40: 658–674.

[54] Grammel M, Luong P, Orth K, Hang HC. A chemical reporter for protein AMPylation. J Am Chem Soc. 2011; 133: 17103–17105.

Rights & permissions

2026 The Author(s). mLife published by John Wiley & Sons Australia, Ltd on behalf of Institute of Microbiology, Chinese Academy of Sciences.